Proceedings of the National Academy of SciencesBioinformaticsPeer-reviewed journal article
Accurate Identification and Mechanistic Evaluation of Pathogenic Missense Variants with Rhapsody-2
Abstract
Understanding the effects of missense mutations or single amino acid variants (SAVs) on protein function is crucial for elucidating the molecular basis of diseases/disorders and designing rational therapies. We introduce here Rhapsody-2, a machine learning tool for discriminating pathogenic and neutral SAVs, significantly expanding on a precursor limited by the availability of structural data. With the advent of AlphaFold2 as a powerful tool for structure prediction, Rhapsody-2 is trained on a significantly expanded dataset of 117,525 SAVs corresponding to 12,094 human proteins reported in the ClinVar database. Adopting a broad set of descriptors composed of sequence evolutionary, structural, dynamic, and energetics features in the training algorithm, Rhapsody-2 achieved an AUROC of 0.94 in 10-fold cross-validation when all SAVs of a particular test protein (mutant) were excluded from the training set. Benchmarking against a variety of testing datasets demonstrated the high performance of Rhapsody-2. While sequence evolutionary descriptors play a dominant role in pathogenicity prediction, those based on structural dynamics provide a mechanistic interpretation. Notably, residues involved in allosteric communication, and those distinguished by pronounced fluctuations in the high frequency modes of motion or subject to spatial constraints in soft modes usually give rise to pathogenicity when mutated. Overall, Rhapsody-2 provides an efficient and transparent tool for accurately predicting the pathogenicity of SAVs and unraveling the mechanistic basis of the observed behavior, thus advancing our understanding of genotype-to-phenotype relations. Significance StatementUnderstanding the impact of single amino acid variants (SAVs) on protein function is pivotal for detecting and treating genetic disorders. We present Rhapsody-2, a machine learning tool that leverages AlphaFold2-predicted protein structures to accurately predict the pathogenicity of SAVs. By integrating sequence, structure, and dynamics properties, Rhapsody-2 achieves a high performance in distinguishing pathogenic variants across multiple benchmark datasets. Our tool not only provides a robust framework for predicting the impact of SAVs but also allows for mechanistic interpretability of pathogenicity, offering a valuable resource for understanding genotype-to-phenotype relationships toward assisting in precision medicine.
- organism: human
- assay: protein structure
- research focus: variant effect prediction
- approach: machine learning (classical)
- Citations
- 13
- FWCI
- 7.60
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rhapsody: Pathogenicity prediction of human missense variants based on protein sequence, structure and dynamics
Luca Ponzoni, Daniel Peñaherrera, … İvet Bahar·BioinformaticsPeer-reviewed·Feb 21, 2020
- AFFIPred: AlphaFold2 Structure-based Functional Impact Prediction of Missense Variations
Mustafa S Pir, Emel Timuçin·Protein SciencePeer-reviewed·Jan 22, 2025
- LYRUS: A Machine Learning Model for Predicting the Pathogenicity of Missense Variants
Jiaying Lai, Jordan Yang, … Indra Neil Sarkar·Bioinformatics AdvancesPeer-reviewed·Dec 22, 2021
- Predicting the pathogenicity of missense variants using features derived from AlphaFold2
Axel Schmidt, Sebastian Röner, … Kerstin U. Ludwig·BioinformaticsPeer-reviewed·Apr 21, 2023
- pLM-SAV: A Δ-Embedding Approach for Predicting Pathogenic Single Amino Acid Variants
Orsolya Gereben, Hedvig Tordai, … Tamás Hegedűs·Bioinformatics AdvancesPeer-reviewed·Jan 1, 2026
- MutPred2: inferring the molecular and phenotypic impact of amino acid variants
Vikas Rao Pejaver, Jorge Urresti, … Predrag Radivojac A·Nature CommunicationsPeer-reviewed·Nov 20, 2020